Skip to main content

D. E. Shaw & Co., Inc.

Position in ESPR — Esperion Therapeutics, Inc.

CIK 1009207 New York, NY

Position in ESPR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
6,540,785
-5.3% QoQ
Ownership
2.54%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ESPR Over Time

Shares Held

Position Value (USD)

Derivatives in ESPR

reported options exposure · as of Dec 31, 2021
CallValue
$0
CallShares
0
PutValue
$0
PutShares
12,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $657,589,731 across 42 Drug Manufacturers - Specialty & Generic names.

# Ticker Company Shares Value (USD) Open

All Filings in ESPR

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-03-31 6,540,785
2025-12-31 6,903,483
2025-09-30 208,633
2025-03-31 275,707
2024-12-31 251,592
2024-09-30 99,573
2024-06-30 382,488
2024-03-31 5,143,486
2023-12-31 1,213,203
2022-09-30 351,039
2022-06-30 703,478
2022-03-31 637,436
2021-12-31 12,500
2021-12-31 884,472
2021-09-30 23,079
2021-09-30 12,500
2020-12-31 20,000
2020-09-30 20,000
2020-06-30 20,000
2020-03-31 7,125
2020-03-31 20,000